Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCGB Conditioning for ASCT in R/R DLBCL
NCT03151876Phase 2Unknown
- Sponsor
- Sichuan University
- Start
- Jun 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in diffuse large B-cell lymphoma (DLBCL), sponsored by Sichuan University. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03151876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03151876.